June 21, 2007
New Entry Inhibitor Is “Approvable”
The FDA has sent Pfizer an “approvable letter” for its new entry inhibitor, Celsentri, which probably means marketing clearance for the HIV med is imminent. Celsentri could prove a lifesaver for many who are treatment-experienced.
[Go to top]